VIDEOS

2023/11/27: Understand Biomunex’ technology and outlooks in 3 questions to Pierre Emmanuel Gerard, founder and CEO, and Simon Plyte, CSO

2023/09/20: SACHS 23rd Annual Biotech in Europe Forum – Presentation of Biomunex by Pierre-Emmanuel Gerard, CEO

2022/09/22: SACHS 22nd Annual Biotech in Europe Forum – Presentation of Biomunex by Pierre-Emmanuel Gerard, CEO

2019/06/28 : Paroles d’experts Latribune.com TV : « Le Président de Biomunex présente la stratégie de Biomunex et la technologie BiXAb

2018/07/11 : Realize AstraZeneca : « Pierre-Emmanuel Gerard présente Biomunex Pharmaceuticals qui travaille au développement d’anticorps bispécifiques en immuno-oncologie

2017/04/25: BIO-Europe Spring® 2017: Biomunex CSO defines lead compounds, early R&D plans

2017/04/25: BIO-Europe Spring® 2017: Biomunex CEO on earlier deals for cancer drugs

ARTICLES

2023/04/20: Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer

2017/02/27: Interviews: Bispecific Antibodies Close in on Cancer (GEN EXLUSIVES)